ANVS peer analysis
Annovis Bio (ANVS) against its competitors: price, today's move, 1-year return and market value side by side.
ANVS and its peers
| Company | Price | Today | 1-year return | Market cap |
|---|---|---|---|---|
| ATNM Actinium Pharmaceuticals | $1.41 | 0.71% | 4.44% | $44.33M |
| CELU Celularity | $0.81 | -1.02% | -52.98% | – |
| ELUT Elutia | $0.76 | -6.59% | -17.43% | – |
| EVAX Evaxion | $2.97 | 0.34% | -46.96% | – |
| MAIA MAIA Biotechnology | $1.14 | 5.56% | 3.64% | – |
| PDSB PDS Biotechnology | $1.17 | -10.38% | 31.12% | $94.22M |
| PYPD PolyPid | $5.82 | 6.59% | 51.56% | $118.21M |
| ANVS Annovis Bio | $1.21 | 11.01% | -35.98% | $51.64M |
- ANVS's peers: ATNM (Actinium Pharmaceuticals), CELU (Celularity), ELUT (Elutia), EVAX (Evaxion), MAIA (MAIA Biotechnology), PDSB (PDS Biotechnology), PYPD (PolyPid).
Updated 2026-11-06 07:48 UTC